Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001595585-22-000067
Filing Date
2022-08-08
Accepted
2022-08-08 16:17:53
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcda-20220630.htm   iXBRL 10-Q 1082313
2 EX-31.1 exhibit311ceo302certificat.htm EX-31.1 9880
3 EX-31.2 exhibit312cfo302certificat.htm EX-31.2 9858
4 EX-32.1 exhibit321ceoandcfo906cert.htm EX-32.1 7788
10 GRAPHIC tcda-20220630_g1.jpg GRAPHIC 34563
  Complete submission text file 0001595585-22-000067.txt   4733806

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20220630.xsd EX-101.SCH 24797
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20220630_cal.xml EX-101.CAL 55959
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20220630_def.xml EX-101.DEF 129987
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20220630_lab.xml EX-101.LAB 355516
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20220630_pre.xml EX-101.PRE 230144
45 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20220630_htm.xml XML 797892
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38558 | Film No.: 221144637
SIC: 2834 Pharmaceutical Preparations